CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,485,567 | +7.9% | 162,993 | +33.0% | 0.01% | -26.7% |
| Q2 2023 | $4,158,189 | +65.5% | 122,552 | +75.5% | 0.02% | -60.5% |
| Q1 2023 | $2,511,980 | -34.4% | 69,816 | -18.8% | 0.04% | -44.9% |
| Q4 2022 | $3,831,772 | -20.7% | 85,972 | -50.0% | 0.07% | -25.0% |
| Q3 2022 | $4,832,000 | +279.6% | 171,902 | +359.9% | 0.09% | +170.6% |
| Q1 2022 | $1,273,000 | +131.5% | 37,381 | +162.7% | 0.03% | +100.0% |
| Q4 2021 | $550,000 | – | 14,227 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
| Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
| TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
| Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
| COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
| Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
| Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
| RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
| Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |